{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:56:27Z","timestamp":1791600987685,"version":"4.3.4"},"reference-count":107,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Ministry of Health \u2018Ricerca Corrente\u2019 funding program"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.tips.2018.02.009","type":"journal-article","created":{"date-parts":[[2018,3,17]],"date-time":"2018-03-17T21:16:19Z","timestamp":1521321379000},"page":"468-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The S1P Axis: New Exciting Route for Treating Huntington\u2019s Disease"],"prefix":"10.1016","volume":"39","author":[{"given":"Alba","family":"Di Pardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2018.02.009_bib0005","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington\u2019s disease: mechanisms of pathogenesis and therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.tips.2018.02.009_bib0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders","volume":"421","author":"Sanchez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.tips.2018.02.009_bib0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","article-title":"Autophagy in Huntington disease and huntingtin in autophagy","volume":"38","author":"Martin","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2018.02.009_bib0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1073858410390378","article-title":"Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease","volume":"17","author":"Ehrnhoefer","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.tips.2018.02.009_bib0025","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2018.02.009_bib0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2005.09.037","article-title":"The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington\u2019s disease patients with predominant chorea","volume":"393","author":"Maglione","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tips.2018.02.009_bib0035","article-title":"Huntington\u2019s disease is a multi-system disorder","volume":"3","author":"Mielcarek","year":"2015","journal-title":"Rare Dis."},{"key":"10.1016\/j.tips.2018.02.009_bib0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1051\/jbio:2005026","article-title":"Huntington\u2019s disease: intracellular signaling pathways and neuronal death","volume":"199","author":"Humbert","year":"2005","journal-title":"J. Soc. Biol."},{"key":"10.1016\/j.tips.2018.02.009_bib0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JHD-140106","article-title":"Kinase signalling in Huntington\u2019s disease","volume":"3","author":"Bowles","year":"2014","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.tips.2018.02.009_bib0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fneur.2013.00127","article-title":"Multiple aspects of gene dysregulation in Huntington\u2019s disease","volume":"4","author":"Moumne","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tips.2018.02.009_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-140134","article-title":"Epigenetic mechanisms involved in Huntington\u2019s disease pathogenesis","volume":"4","author":"Glajch","year":"2015","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.tips.2018.02.009_bib0060","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12035-014-8715-8","article-title":"Transcription, epigenetics and ameliorative strategies in Huntington\u2019s disease: a genome-wide perspective","volume":"51","author":"Valor","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2018.02.009_bib0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tips.2018.02.009_bib0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-3-642-45106-5_14","article-title":"Huntington\u2019s disease","volume":"220","author":"Zuccato","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.tips.2018.02.009_bib0075","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bbalip.2014.12.018","article-title":"The impairment of cholesterol metabolism in Huntington disease","volume":"1851","author":"Leoni","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2018.02.009_bib0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nbd.2007.05.003","article-title":"Glycolipid and ganglioside metabolism imbalances in Huntington\u2019s disease","volume":"27","author":"Desplats","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2018.02.009_bib0085","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1523\/JNEUROSCI.6348-09.2010","article-title":"Impaired ganglioside metabolism in Huntington\u2019s disease and neuroprotective role of GM1","volume":"30","author":"Maglione","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2018.02.009_bib0090","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nmeth.3940","article-title":"Revealing disease-associated pathways by network integration of untargeted metabolomics","volume":"13","author":"Pirhaji","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tips.2018.02.009_bib0095","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41467-017-00353-6","article-title":"Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements","volume":"8","author":"Pirhaji","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2018.02.009_bib0100","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1038\/s41598-017-05709-y","article-title":"Defective sphingosine-1-phosphate metabolism is a druggable target in Huntington\u2019s disease","volume":"7","author":"Di Pardo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2018.02.009_bib0105","doi-asserted-by":"crossref","first-page":"43030","DOI":"10.1038\/srep43030","article-title":"Metabolic profiling of presymptomatic Huntington\u2019s disease sheep reveals novel biomarkers","volume":"7","author":"Skene","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2018.02.009_bib0110","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1007\/s00018-007-7076-0","article-title":"The metabolism and function of sphingolipids and glycosphingolipids","volume":"64","author":"Lahiri","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tips.2018.02.009_bib0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","article-title":"Sphingosine-1-phosphate signaling and its role in disease","volume":"22","author":"Maceyka","year":"2012","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tips.2018.02.009_bib0120","first-page":"5","article-title":"Sphingosine-1-phosphate: distribution, metabolism and role in the regulation of cellular functions","volume":"85","author":"Morozov","year":"2013","journal-title":"Ukr. Biokhim. Zh. (1999)"},{"key":"10.1016\/j.tips.2018.02.009_bib0125","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/biom3030408","article-title":"Emerging role of sphingosine-1-phosphate in inflammation, cancer, and lymphangiogenesis","volume":"3","author":"Huang","year":"2013","journal-title":"Biomolecules"},{"key":"10.1016\/j.tips.2018.02.009_bib0130","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1096\/fj.10-167502","article-title":"Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration","volume":"25","author":"Strub","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2018.02.009_bib0135","first-page":"149","article-title":"Sphingosine-1 phosphate and central nervous system","volume":"378","author":"Martin","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.tips.2018.02.009_bib0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1242\/dev.094805","article-title":"Sphingosine 1-phosphate signalling","volume":"141","author":"Mendelson","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.tips.2018.02.009_bib0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4068\/cmj.2011.47.1.27","article-title":"Effects of sphingosine-1-phosphate on neural differentiation and neurite outgrowth in neuroblastoma cells","volume":"47","author":"Lee","year":"2011","journal-title":"Chonnam Med. J."},{"key":"10.1016\/j.tips.2018.02.009_bib0150","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmed.2015.03.006","article-title":"Sphingosine 1-phosphate signaling at the blood-brain barrier","volume":"21","author":"Prager","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tips.2018.02.009_bib0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1388-1981(02)00341-4","article-title":"Sphingosine kinase, sphingosine-1-phosphate, and apoptosis","volume":"1585","author":"Maceyka","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2018.02.009_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027150","article-title":"Loss of sphingosine kinase 1\/S1P signaling impairs cell growth and survival of neurons and progenitor cells in the developing sensory ganglia","volume":"6","author":"Meng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2018.02.009_bib0165","doi-asserted-by":"crossref","first-page":"37118","DOI":"10.1074\/jbc.M502207200","article-title":"SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism","volume":"280","author":"Maceyka","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2018.02.009_bib0170","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.bbamem.2006.08.007","article-title":"Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases","volume":"1758","author":"Hait","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2018.02.009_bib0175","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1176709","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.tips.2018.02.009_bib0180","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/hmg\/ddx046","article-title":"Inhibiting sphingosine kinase 2 mitigates mutant huntingtin-induced neurodegeneration in neuron models of Huntington disease","volume":"26","author":"Moruno-Manchon","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2018.02.009_bib0185","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1128\/MCB.02107-05","article-title":"Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-Golgi trafficking of ceramide","volume":"26","author":"Giussani","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tips.2018.02.009_bib0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.advenzreg.2009.10.024","article-title":"Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function","volume":"50","author":"Serra","year":"2010","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.tips.2018.02.009_bib0195","doi-asserted-by":"crossref","first-page":"178910","DOI":"10.1155\/2013\/178910","article-title":"Sphingolipid metabolic pathway: an overview of major roles played in human diseases","volume":"2013","author":"Pralhada Rao","year":"2013","journal-title":"J. Lipids"},{"key":"10.1016\/j.tips.2018.02.009_bib0200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11064-007-9297-x","article-title":"Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer\u2019s disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer\u2019s disease?","volume":"32","author":"Katsel","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tips.2018.02.009_bib0205","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.neuroscience.2015.01.032","article-title":"Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson\u2019s disease and in MPP+-treated MN9D cells in vitro","volume":"290","author":"Sivasubramanian","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2018.02.009_bib0210","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5114\/fn.2014.45567","article-title":"The key role of sphingosine kinases in the molecular mechanism of neuronal cell survival and death in an experimental model of Parkinson\u2019s disease","volume":"52","author":"Pyszko","year":"2014","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.tips.2018.02.009_bib0215","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbamem.2017.03.008","article-title":"Sphingosine 1-phosphate \u2013 a double edged sword in the brain","volume":"1859","author":"Karunakaran","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2018.02.009_bib0220","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1523\/JNEUROSCI.6467-10.2011","article-title":"BACE1 activity is modulated by cell-associated sphingosine-1-phosphate","volume":"31","author":"Takasugi","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2018.02.009_bib0225","doi-asserted-by":"crossref","first-page":"16761","DOI":"10.1074\/jbc.M113.535500","article-title":"Deficiency of sphingosine-1-phosphate lyase impairs lysosomal metabolism of the amyloid precursor protein","volume":"289","author":"Karaca","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2018.02.009_bib0230","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/15548627.2017.1291471","article-title":"SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production","volume":"13","author":"Mitroi","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.tips.2018.02.009_bib0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2051-5960-2-12","article-title":"Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer\u2019s disease","volume":"2","author":"Ceccom","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tips.2018.02.009_bib0240","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1051\/medsci\/20143005006","article-title":"Sphingosine 1-phosphate as a biomarker for Alzheimer\u2019s disease?","volume":"30","author":"Ceccom","year":"2014","journal-title":"Med. Sci. (Paris)"},{"key":"10.1016\/j.tips.2018.02.009_bib0245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2051-5960-2-9","article-title":"Loss of the neuroprotective factor sphingosine 1-phosphate early in Alzheimer\u2019s disease pathogenesis","volume":"2","author":"Couttas","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tips.2018.02.009_bib0250","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","article-title":"Emerging roles for cholesterol in Huntington\u2019s disease","volume":"34","author":"Valenza","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2018.02.009_bib0255","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-319-20825-1_8","article-title":"Endocannabinoids and neurodegenerative disorders: Parkinson\u2019s disease, Huntington\u2019s chorea, Alzheimer\u2019s disease, and others","volume":"231","author":"Fernandez-Ruiz","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.tips.2018.02.009_bib0260","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/JHD-130068","article-title":"Huntingtin interactions with membrane phospholipids: strategic targets for therapeutic intervention?","volume":"2","author":"Kegel-Gleason","year":"2013","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.tips.2018.02.009_bib0265","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.febslet.2009.12.010","article-title":"Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction","volume":"584","author":"Posse de Chaves","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2018.02.009_bib0270","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","article-title":"FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease","volume":"23","author":"Di Pardo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2018.02.009_bib0275","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fnins.2016.00457","article-title":"Impaired levels of gangliosides in the corpus callosum of huntington disease animal models","volume":"10","author":"Di Pardo","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tips.2018.02.009_bib0280","series-title":"Neurobiology of Huntington\u2019s Disease: Applications to Drug Discovery","first-page":"165","article-title":"Mouse models for validating preclinical candidates for Huntington\u2019s disease","author":"William Yang","year":"2011"},{"key":"10.1016\/j.tips.2018.02.009_bib0285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/brainsci7060063","article-title":"Striatal vulnerability in Huntington\u2019s disease: neuroprotection versus neurotoxicity","volume":"7","author":"Morigaki","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.tips.2018.02.009_bib0290","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00427-7","article-title":"Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington\u2019s disease using high resolution image analysis","volume":"64","author":"Sapp","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2018.02.009_bib0295","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","article-title":"Decreased neuronal and increased oligodendroglial densities in Huntington\u2019s disease caudate nucleus","volume":"50","author":"Myers","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tips.2018.02.009_bib0300","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2012.01.038","article-title":"Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis","volume":"148","author":"Chipuk","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tips.2018.02.009_bib0305","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molcel.2012.04.033","article-title":"The Sj\u00f6gren\u2013Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway","volume":"46","author":"Nakahara","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2018.02.009_bib0310","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ncb2987","article-title":"Coupling between endocytosis and sphingosine kinase 1 recruitment","volume":"16","author":"Shen","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tips.2018.02.009_bib0315","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1038\/ncomms6514","article-title":"Pathological roles of the VEGF\/SphK pathway in Niemann\u2013Pick type C neurons","volume":"5","author":"Lee","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2018.02.009_bib0320","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1101\/gad.188003.112","article-title":"Recruitment of sphingosine kinase to presynaptic terminals by a conserved muscarinic signaling pathway promotes neurotransmitter release","volume":"26","author":"Chan","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.tips.2018.02.009_bib0325","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.neuroscience.2010.10.021","article-title":"Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus","volume":"171","author":"Kanno","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2018.02.009_bib0330","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11596-013-1136-5","article-title":"Effects of small interfering RNA targeting sphingosine kinase-1 gene on the animal model of Alzheimer\u2019s disease","volume":"33","author":"Zhang","year":"2013","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"key":"10.1016\/j.tips.2018.02.009_bib0335","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JHD-120023","article-title":"Cognitive dysfunction in Huntington\u2019s disease: humans, mouse models and molecular mechanisms","volume":"1","author":"Giralt","year":"2012","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.tips.2018.02.009_bib0340","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00018-012-1038-x","article-title":"Ceramide function in the brain: when a slight tilt is enough","volume":"70","author":"Mencarelli","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tips.2018.02.009_bib0345","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1093\/emboj\/cdg540","article-title":"Activation of sphingosine kinase 1 by ERK1\/2-mediated phosphorylation","volume":"22","author":"Pitson","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.tips.2018.02.009_bib0350","doi-asserted-by":"crossref","first-page":"12058","DOI":"10.1074\/jbc.M609559200","article-title":"Sphingosine kinase type 2 activation by ERK-mediated phosphorylation","volume":"282","author":"Hait","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2018.02.009_bib0355","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ab.2006.05.024","article-title":"Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry","volume":"354","author":"Zhan","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tips.2018.02.009_bib0360","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/ars.2012.4928","article-title":"S-Nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington\u2019s disease","volume":"19","author":"Haun","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tips.2018.02.009_bib0365","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1093\/hmg\/ddv218","article-title":"Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington\u2019s disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation","volume":"24","author":"Miguez","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2018.02.009_bib0370","doi-asserted-by":"crossref","first-page":"15213","DOI":"10.1038\/srep15213","article-title":"Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy","volume":"5","author":"Moruno Manchon","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2018.02.009_bib0375","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3389\/fnins.2017.00698","article-title":"De novo synthesis of sphingolipids is defective in experimental models of Huntington\u2019s disease","volume":"11","author":"Di Pardo","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tips.2018.02.009_bib0380","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1074\/jbc.M116.762377","article-title":"Sphingosine and sphingosine kinase 1 involvement in endocytic membrane trafficking","volume":"292","author":"Lima","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2018.02.009_bib0385","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1080\/15548627.2016.1183082","article-title":"SPHK1\/sphingosine kinase 1-mediated autophagy differs between neurons and SH-SY5Y neuroblastoma cells","volume":"12","author":"Moruno Manchon","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.tips.2018.02.009_bib0390","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbrc.2015.02.007","article-title":"K6PC-5, a novel sphingosine kinase 1 (SphK1) activator, alleviates dexamethasone-induced damages to osteoblasts through activating SphK1\u2013Akt signaling","volume":"458","author":"Ji","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2018.02.009_bib0395","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nbd.2010.02.003","article-title":"The role of REST in transcriptional and epigenetic dysregulation in Huntington\u2019s disease","volume":"39","author":"Buckley","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2018.02.009_bib0400","article-title":"The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: recent findings and new perspectives","author":"Huwiler","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tips.2018.02.009_bib0405","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1523\/JNEUROSCI.1592-09.2009","article-title":"Alterations in cortical excitation and inhibition in genetic mouse models of Huntington\u2019s disease","volume":"29","author":"Cummings","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2018.02.009_bib0410","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jnr.20344","article-title":"Increased GABAergic function in mouse models of Huntington\u2019s disease: reversal by BDNF","volume":"78","author":"Cepeda","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tips.2018.02.009_bib0415","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nchembio.582","article-title":"Kinase inhibitors modulate huntingtin cell localization and toxicity","volume":"7","author":"Atwal","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2018.02.009_bib0420","doi-asserted-by":"crossref","first-page":"14610","DOI":"10.1073\/pnas.1301342110","article-title":"Polyglutamine domain flexibility mediates the proximity between flanking sequences in huntingtin","volume":"110","author":"Caron","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2018.02.009_bib0425","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1073\/pnas.1114502109","article-title":"Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice","volume":"109","author":"Di Pardo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2018.02.009_bib0430","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.15252\/emmm.201707763","article-title":"Disease-modifying effects of ganglioside GM1 in Huntington\u2019s disease models","volume":"9","author":"Alpaugh","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.tips.2018.02.009_bib0435","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12035-009-8096-6","article-title":"Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders","volume":"41","author":"Piccinini","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2018.02.009_bib0440","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s12035-015-9136-z","article-title":"GM1 ganglioside: past studies and future potential","volume":"53","author":"Aureli","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2018.02.009_bib0445","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.116","article-title":"Imbalance of p75(NTR)\/TrkB protein expression in Huntington\u2019s disease: implication for neuroprotective therapies","volume":"4","author":"Brito","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2018.02.009_bib0450","doi-asserted-by":"crossref","first-page":"16090","DOI":"10.1074\/jbc.M807438200","article-title":"Ceramide synthesis is modulated by the sphingosine analog FTY720 via a mixture of uncompetitive and noncompetitive inhibition in an acyl-CoA chain length-dependent manner","volume":"284","author":"Lahiri","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2018.02.009_bib0455","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1074\/jbc.M805186200","article-title":"FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells","volume":"284","author":"Berdyshev","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2018.02.009_bib0460","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1182\/blood-2006-03-011437","article-title":"The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors","volume":"109","author":"Payne","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tips.2018.02.009_bib0465","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/mol.105.020552","article-title":"Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-4-octylphenylethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor","volume":"70","author":"Paugh","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2018.02.009_bib0470","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","article-title":"Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis","volume":"33","author":"Chun","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.tips.2018.02.009_bib0475","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s12272-010-1008-5","article-title":"Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis","volume":"33","author":"Lee","year":"2010","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.tips.2018.02.009_bib0480","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tips.2018.02.009_bib0485","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1474-4422(15)00177-5","article-title":"Treating the whole body in Huntington\u2019s disease","volume":"14","author":"Carroll","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2018.02.009_bib0490","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tins.2015.08.003","article-title":"The molecular constituents of the blood\u2013brain barrier","volume":"38","author":"Chow","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2018.02.009_bib0495","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3233\/JAD-2011-110368","article-title":"The role of the blood brain barrier in neurodegenerative disorders and their treatment","volume":"24","author":"Palmer","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2018.02.009_bib0500","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood\u2013brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2018.02.009_bib0505","doi-asserted-by":"crossref","first-page":"41316","DOI":"10.1038\/srep41316","article-title":"Impairment of blood\u2013brain barrier is an early event in R6\/2 mouse model of Huntington disease","volume":"7","author":"Di Pardo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2018.02.009_bib0510","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrd4099","article-title":"Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond","volume":"12","author":"Kunkel","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2018.02.009_bib0515","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4062\/biomolther.2016.160","article-title":"Sphingosine 1-phosphate receptor modulators and drug discovery","volume":"25","author":"Park","year":"2017","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.tips.2018.02.009_bib0520","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00401-017-1722-x","article-title":"Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins","volume":"134","author":"Flavin","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tips.2018.02.009_bib0525","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington\u2019s disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2018.02.009_bib0530","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-2011-110405","article-title":"Plasma sphingomyelins are associated with cognitive progression in Alzheimer\u2019s disease","volume":"27","author":"Mielke","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2018.02.009_bib0535","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1194\/jlr.M040618","article-title":"Identification of Niemann\u2013Pick C1 disease biomarkers through sphingolipid profiling","volume":"54","author":"Fan","year":"2013","journal-title":"J. Lipid Res."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614718300476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614718300476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T18:30:11Z","timestamp":1575397811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614718300476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":107,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0165614718300476"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2018.02.009","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The S1P Axis: New Exciting Route for Treating Huntington\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2018.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}